These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8362984)

  • 41. Intron structure of the human antithrombin III gene differs from that of other members of the serine protease inhibitor superfamily.
    Prochownik EV; Bock SC; Orkin SH
    J Biol Chem; 1985 Aug; 260(17):9608-12. PubMed ID: 2991253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunocytochemical localization of endogenous anti-thrombin III in the vasculature of rat tissues reveals locations of anticoagulantly active heparan sulfate proteoglycans.
    Xu Y; Slayter HS
    J Histochem Cytochem; 1994 Oct; 42(10):1365-76. PubMed ID: 7930519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier.
    Kalaria RN; Golde TE; Cohen ML; Younkin SG
    Ann N Y Acad Sci; 1991; 640():145-8. PubMed ID: 1776732
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Lu Z; Wang F; Liang M
    Clin Sci (Lond); 2017 May; 131(9):823-831. PubMed ID: 28424376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease.
    Webster S; Lue LF; Brachova L; Tenner AJ; McGeer PL; Terai K; Walker DG; Bradt B; Cooper NR; Rogers J
    Neurobiol Aging; 1997; 18(4):415-21. PubMed ID: 9330973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular genetics of inherited antithrombin III deficiencies.
    Prochownik EV
    Am J Med; 1989 Sep; 87(3B):15S-18S. PubMed ID: 2572168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues.
    Hino H; Akiyama H; Iseki E; Kato M; Kondo H; Ikeda K; Kosaka K
    Neurosci Lett; 2001 Jan; 297(2):105-8. PubMed ID: 11121881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of 8-oxoguanine DNA glycosylase is reduced and associated with neurofibrillary tangles in Alzheimer's disease brain.
    Iida T; Furuta A; Nishioka K; Nakabeppu Y; Iwaki T
    Acta Neuropathol; 2002 Jan; 103(1):20-5. PubMed ID: 11837743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease.
    Smith MA; Rudnicka-Nawrot M; Richey PL; Praprotnik D; Mulvihill P; Miller CA; Sayre LM; Perry G
    J Neurochem; 1995 Jun; 64(6):2660-6. PubMed ID: 7539057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.
    Itagaki S; Akiyama H; Saito H; McGeer PL
    Brain Res; 1994 May; 645(1-2):78-84. PubMed ID: 8062101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease.
    Yasuhara O; Walker DG; McGeer PL
    Brain Res; 1994 Aug; 654(2):234-40. PubMed ID: 7987673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning.
    Johnson SA; Lampert-Etchells M; Pasinetti GM; Rozovsky I; Finch CE
    Neurobiol Aging; 1992; 13(6):641-8. PubMed ID: 1362796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cerebellum in Alzheimer's disease.
    Larner AJ
    Dement Geriatr Cogn Disord; 1997; 8(4):203-9. PubMed ID: 9213064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of polymorphism of antithrombin III at the level of both protein and DNA in a Chinese population.
    Gou Q; Hou Y; Zhang Y; Wu M
    Exp Clin Immunogenet; 1996; 13(2):112-6. PubMed ID: 9063703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.
    Abraham CR; Selkoe DJ; Potter H
    Cell; 1988 Feb; 52(4):487-501. PubMed ID: 3257719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basic fibroblast growth factor in Alzheimer's disease.
    Stopa EG; Gonzalez AM; Chorsky R; Corona RJ; Alvarez J; Bird ED; Baird A
    Biochem Biophys Res Commun; 1990 Sep; 171(2):690-6. PubMed ID: 2403357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between human tissue thromboplastin and human antithrombin III.
    Hirahara K; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):2984-7. PubMed ID: 2632043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.
    Yasojima K; Schwab C; McGeer EG; McGeer PL
    Brain Res; 2000 Dec; 887(1):80-9. PubMed ID: 11134592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some immunological investigations on antithrombin III 'Budapest'.
    Lane JL
    Br J Haematol; 1978 Nov; 40(3):459-70. PubMed ID: 107959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog.
    Chen Y; Tan W; Qin S; Zhang J; Bu H; Li Y; Lu Y; Cheng J
    Comp Med; 2009 Aug; 59(4):372-7. PubMed ID: 19712578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.